AUA2025: AUA Guidelines on Early Detection of Prostate Cancer: Maximizing Benefits, Minimizing Harm
AUAUniversity11 Juni 2025

AUA2025: AUA Guidelines on Early Detection of Prostate Cancer: Maximizing Benefits, Minimizing Harm

AUA2025: AUA Guidelines on Early Detection of Prostate Cancer: Maximizing Benefits, Minimizing Harm CME Available: https://auau.auanet.org/node/43021 At the conclusion of this activity, participants will be able to: 1. Apply the Early Detection of Prostate Cancer: AUA/SUO Guideline (2023), and understand the rationale, evidence, level of evidence, strength of recommendation and applications associated with each statement. 2. Maximize the benefits and minimize the harms of prostate cancer detection by carefully selecting patients and by using the necessary tools to detect clinically significant prostate cancer, while avoiding unnecessary biopsies and detection of clinically insignificant prostate cancers. 3. Describe the evidence supporting the use of PSA for early detection of prostate cancer, and apply that evidence to different clinical scenarios, incorporating patient characteristics and preferences. 4. Identify available blood, urine and tissue biomarkers used to enhance detection of higher-grade prostate cancer, the evidence supporting their use, and the clinical scenarios in which they are most valuable to be used. 5. Use MRI and fusion biopsy to enhance the detection of clinically significant prostate cancer and implement safe biopsy practices with respect to approach, avoidance of infection, and attention to patient comfort; understand the rationale for transperineal prostate biopsy and its technique; be able to establish a transperineal biopsy practice. ACKNOWLEDGEMENTS: This educational activity is supported by independent educational grants from: Astellas, Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, Lantheus Medical Imaging, Novartis Pharmaceuticals Corporation, Pfizer, Inc.

Avsnitt(426)

AUA2019 035IC Contemporary Pharmacotherapy For OAB 2019

AUA2019 035IC Contemporary Pharmacotherapy For OAB 2019

Support provided by an independent educational grant from Allergan, Astellas and Medtronic CME Available: https://auau.auanet.org/node/24584 Instructional Course Director(s) Eric Rovner, MD Medical...

27 Juni 20191h 54min

AUA2019 077IC Establishing A Multidisciplinary Oncology Clinic With Advanced Therapeutics

AUA2019 077IC Establishing A Multidisciplinary Oncology Clinic With Advanced Therapeutics

Support provided by independent educational grants from AbbVie, Amgen, Astellas, AstraZeneca, Bristol-Myers Squibb, Genomic Health, Genentech, Merck, Pfizer, Inc. and Sanofi Genzyme CME Available: h...

20 Juni 20191h 44min

AUA2019 027IC AUA CRPC Guidelines And Therapeutic Advances In Metastatic Prostate Cancer

AUA2019 027IC AUA CRPC Guidelines And Therapeutic Advances In Metastatic Prostate Cancer

Support provided by independent educational grants from AbbVie, Amgen, Astellas, AstraZeneca, Bristol-Myers Squibb, Genomic Health, Genentech, Merck, Pfizer, Inc. and Sanofi Genzyme CME Available: h...

14 Juni 20192h 1min

AUA2019 023IC - Chemotherapy And Immunotherapy Options For Genitourinary Malignancies

AUA2019 023IC - Chemotherapy And Immunotherapy Options For Genitourinary Malignancies

Support provided by independent educational grants from AbbVie, Amgen, Astellas, AstraZeneca, Bristol-Myers Squibb, Genomic Health, Genentech, Merck, Pfizer, Inc. and Sanofi Genzyme CME Available: h...

6 Juni 20191h 49min

AUA2019 076IC - Advanced OAB Therapies - What To Do When 1st And 2nd Line Therapies Do Not Work

AUA2019 076IC - Advanced OAB Therapies - What To Do When 1st And 2nd Line Therapies Do Not Work

Support provided by an independent educational grant from Allergan, Astellas and Medtronic CME Available: https://auau.auanet.org/node/24581 Instructional Course Director(s) Kathleen Kobashi, MD, F...

30 Maj 20191h 58min

AUA2019 013IC Genetic Testing In Prostate Cancer

AUA2019 013IC Genetic Testing In Prostate Cancer

Support provided by independent educational grants from AbbVie, Amgen, Astellas, AstraZeneca, Bristol-Myers Squibb, Genomic Health, Genentech, Merck, Pfizer, Inc. and Sanofi Genzyme CME Available: h...

21 Maj 20191h 57min

Live From AUA2019 Management Of Advanced And Metastatic Urothelial Carcinoma

Live From AUA2019 Management Of Advanced And Metastatic Urothelial Carcinoma

This educational activity is supported by independent educational grants from: Astellas, Merck and Seattle Genetics CME Available: https://auau.auanet.org/node/24777 In this unique presentation, pan...

16 Maj 201955min

Live From AUA2019 Management Of Non - Muscle Invasive Urothelial Carcinoma

Live From AUA2019 Management Of Non - Muscle Invasive Urothelial Carcinoma

This educational activity is supported by independent educational grants from: Astellas, Merck and Seattle Genetics CME Available: https://auau.auanet.org/node/24288 In this unique presentation, pan...

8 Maj 201951min

Populärt inom Utbildning

rss-bara-en-till-om-missbruk-medberoende-2
historiepodden-se
det-skaver
alska-oss
harrisons-dramatiska-historia
nu-blir-det-historia
roda-vita-rosen
johannes-hansen-podcast
allt-du-velat-veta
sektledare
rss-viktmedicinpodden
not-fanny-anymore
i-vantan-pa-katastrofen
sa-in-i-sjalen
rss-max-tant-med-max-villman
rss-basta-livet
rss-sjalsligt-avkladd
sex-pa-riktigt-med-marika-smith
rss-pa-insidan-med-bjorn-rudman
rss-ar-det-rimligt